首页> 外文期刊>Southern Medical Journal >Spontaneous hypothyroidism in the follow up of Graves hyperthyroid patients treated with antithyroid drugs.
【24h】

Spontaneous hypothyroidism in the follow up of Graves hyperthyroid patients treated with antithyroid drugs.

机译:Graves甲状腺功能亢进患者接受抗甲状腺药物治疗后的自发性甲状腺功能减退症。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: Spontaneous hypothyroidism may follow the natural course of Graves disease (GD) after treatment with antithyroid drugs (ATD). Methods: We studied retrospectively 139 remitted Graves hyperthyroid patients treated with ATD, with a follow-up period of 17.5 years (range 6 to 25 years). Elevated serum concentration of thyroid-stimulating hormone and low serum thyroxine concentrations confirmed the diagnosis. RESULTS: Thirteen patients (median age, 41 years; 26 to 48 years) developed spontaneous hypothyroidism, 4 to 144 months (median, 48 months ) following withdrawal of ATD. The prevalence of hypothyroidism was 9.3% and the incidence was 2.3% per year (13/ 563.6 patients/year of observation). There was no association with types of drugs used or the regimens. Spontaneous hypothyroid patients showed elevated titers (P = 0.02) of serum antithyroid peroxidase antibody (TPOAb) at the end of treatment with ATD, compared with the titers found at the beginning. These patients also had higher titers of TPOAb (P= 0.01) in relation to euthyroid patients. In contrast, the changes in serum antithyroglobulin antibody titers were not significant. CONCLUSIONS: Because of the shift from euthyroidism to spontaneous hypothyroidism, GD patients demanded a strict follow up after ATD therapy. It seems that there is an effect of TPOAb on thyroid destruction.
机译:目的:自发性甲状腺功能减退症可能会在接受抗甲状腺药物(ATD)治疗后遵循Graves病(GD)的自然病程。方法:我们回顾性研究了139例接受ATD治疗的Graves甲状腺功能亢进患者,随访时间为17.5年(6至25年)。血清促甲状腺激素水平升高和血清甲状腺素水平低证实了诊断。结果:13名患者(中位年龄41岁; 26至48岁)在退出ATD后4至144个月(中位48个月)发展为自发性甲状腺功能减退症。甲状腺功能减退的患病率为9.3%,每年的发生率为2.3%(13 / 563.6例患者/每年观察)。与使用的药物类型或治疗方案无关。与开始时发现的滴度相比,自发性甲状腺功能减退患者在ATD治疗结束时显示出较高的血清抗甲状腺过氧化物酶抗体(TPOAb)滴度(P = 0.02)。与甲状腺功能正常的患者相比,这些患者的TPOAb滴度更高(P = 0.01)。相反,血清抗甲状腺球蛋白抗体滴度的变化并不明显。结论:由于从正常甲状腺功能减退到自然甲状腺功能减退,GD患者在ATD治疗后需要严格随访。似乎TPOAb对甲状腺破坏有作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号